FLAK 17 CV

General Information


DRACP ID  DRACP04804

Peptide Name   FLAK 17 CV

Sequence  VAKALKALLKALKAL

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  FLAK peptides

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C74H139N19O16

Absent amino acids  CDEFGHIMNPQRSTWY

Common amino acids  AL

Mass  180097

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  11

Net charge  4

Boman Index  1549

Hydrophobicity  110.67

Aliphatic Index  182.67

Half Life 
  Mammalian: 7.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US06875744B2

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.